According to the current analysis of Reports and Data, the global probiotics market was USD 47.1 Billion in 2018 and is projected to grow at a CAGR of 6.8% from 2019 to 2026. The World Health Organization (WHO) defines these products as “live microorganisms which, when administered in sufficient amounts, confer a health benefit on the host.” To be labeled as probiotic, scientific evidence for the health benefit have to be documented by the manufacturer to regulatory authorities such as FDA or European Commission. They play a significant role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Also, the increasing demand has shown that customers prefer products with proven benefits. The growing evidence of well-being benefits affiliated with probiotics for health restoration has improved the customer expectations related to probiotics for health curing functions. This inclination toward a natural, safe, and cost-effective substitute for drugs has led the application of products as pharmaceutical agents. Clinical trials have revealed that they may cure specific diseases or disorders in humans, especially those related to the gastrointestinal tract. However, ample investments in R&D activities and investments in research equipment, laboratories, and the high cost of hiring trained professionals are expected to create barriers for the growth of the market. The scientific validation concerning the usage of probiotics in their applications becomes a breakthrough to the market. Applications are correlated with health benefits, which make it challenging for industry players to get a satisfactory return on investments on high initial investments due to the high intensity of competition from pharmaceutical, biotechnological and food and beverage industries to establish their foot print in the market.
Probiotics strains and products are developed and produced as per the international food regulations such as Food and Agriculture Organization of the United Nations (FAO) and WHO. Marketing of these products also adds to the product price, as they require different packaging and distribution channels as compared to conventional products. Due to the steep cost of production, the cost of the ultimate outcome is also at a high value.
The Asia Pacific region is foreseen to be the fastest-growing market with CAGR 7.6% during the forecast period, due to the increasing disposable income and the boom in demand for dietary supplements, along with the burgeoning technology base, spanning to the increased demand for probiotics in the region. The rapid commercial growth in countries such as Brazil, Argentina, China, and Japan has led to a notable accretion in the disposable incomes of livestock owners. This, in turn, is spurring the demand for probiotics-based food, making Asia Pacific the fastest-growing market globally. According to a report, the Indian market is growing at a CAGR of 6% in 2018, which is showing profitable opportunities for the companies.
Download PDF Sample Copy: https://www.reportsanddata.com/sample-enquiry-form/2423
Further key findings from the report suggest
- By ingredient type, yeast ingredients are expected to grow at a CAGR of 6.1% during the forecast period. Various biological activities associated with yeast-based and bacteria-based probiotics ingredients make them supreme for use in a variety of applications exceeding the food sector. Notwithstanding their contribution to fermented foods concerning flavor innovation, yeast-based ingredients aid to enhance the health and productivity in growing and lactating animals. Saccharomyces Boulardii is the most broadly used yeast type in the industry owing to its restorative property to help withstand harsh bile and pancreatic juices and other stomach acids.
- Government regulations differ among countries. However, the status of probiotics as a component in food is currently not established on an international basis. For the most part, these come under food and dietary supplements because most are delivered by mouth as foods. These are differentiated from drugs in several ways, especially for claims. Medications are allowed to claim effectiveness in the mitigation, treatment, or cure of a disease, whereas feed additives, foods, and dietary supplements can only make general health claims. CFU (colony forming units) is currently the most widely recognized measure of live microbial used by FDA and foreign governmental organizations.
- BioGaia AB, Danone, Chr. Hansen Holding, Yakult Honsha Co. Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., Du Pont, and Protexin are some of the significant players in the market. In July 2019, DuPont opened a world-class fermentation unit to expand its capacity. The plant is now producing high-quality probiotics for food and beverage industries, which have the potential to afford health benefits to users of all ages.
Ask a Discount: https://www.reportsanddata.com/discount-enquiry-form/2423
Segments covered in the report:
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the probiotics market on the basis of ingredient, function, form, application, end use, distribution channel, and region:
Function (Qualitative analysis)
- Regular
- Preventative Healthcare
- Therapeutic
Ingredient (Revenue, USD Million; 2019-2026)
- Bacteria
- Lactobacilli
- Lactobacillus Acidophilus
- Lactobacillus Rhamnosus
- Lactobacillus Casei
- Lactobacillus Reuteri
- Other species
- Streptococcus Thermophilus
- Bifidobacterium
- Escherichia
- Enterococcus
- Others
- Lactobacilli
- Yeast
- Saccharomyces boulardii
- Others (Cerevisiae Species)
Form (Revenue, USD Million; 2019-2026)
- Powder
- Liquid
- Others
Application (Revenue, USD Million; 2019-2026)
- Probiotic Food & Beverages
- Food
- Cereals
- Baked goods
- Fermented meat
- Dairy-based food
- Others
- Food
- Beverages
- Dairy-based beverages
- Non-Alcoholic beverages
- Functional beverages
- Others
- Probiotic Dietary Supplements
- Food Supplements
- Nutritional Supplements
- Specialty Supplements
- Infant Formula
- Animal Feed Probiotics
End user (Revenue, USD Million; 2019-2026)
- Human Probiotics
- Animal Probiotics
Distribution Channel (Revenue, USD Million; 2019-2026)
- Hypermarkets/Supermarkets
- Pharmacies/Drugstores
- Specialty Stores
- Online Stores
Regional Outlook (Revenue, USD Million; 2019-2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Request for Customization: https://www.reportsanddata.com/request-customization-form/2423
Browse More Reports:
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: [email protected]
Reports and Data | Web: www.reportsanddata.com
News: www.reportsanddata.com/market-news
